VEGFA and squamous cell carcinoma: In a study to evaluate the antiproliferative and antiangiogenic effects on HSC-3, HN-8, and HN-30 squamous cell carcinoma cells, ORV showed a dose-dependent inhibition of cell growth through the suppression of vascular endothelial growth factor (VEGF) expression at both the mRNA and protein levels [215].